Akebia Therapeutics, Inc. (FRA:AX9)
Germany · Delayed Price · Currency is EUR 1.184
+0.004 (0.34%)
At close: Jan 30, 2026
Akebia Therapeutics Market Cap
Akebia Therapeutics has a market cap or net worth of €314.94 million as of January 30, 2026. Its market cap has decreased by -23.44% in one year.
Market Cap
314.94M
Enterprise Value
342.34M
Revenue
191.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.18
Market Cap Chart
Since March 21, 2014, Akebia Therapeutics's market cap has decreased from 331.28M to 314.94M, a decrease of -4.93%. That is a compound annual growth rate of -0.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 314.94M | -13.45% |
| Dec 31, 2025 | 363.88M | -9.12% |
| Dec 31, 2024 | 400.41M | 89.46% |
| Dec 29, 2023 | 211.34M | 112.79% |
| Dec 30, 2022 | 99.32M | -71.43% |
| Dec 31, 2021 | 347.68M | 5.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HOMAG Group AG | 414.16M |
| Eisen- und Hüttenwerke AG | 387.20M |
| Novabase S.G.P.S. | 352.86M |
| SIMONA Aktiengesellschaft | 300.00M |
| EUWAX Aktiengesellschaft | 267.80M |
| centrotherm international AG | 241.25M |
| STINAG Stuttgart Invest AG | 232.23M |
| Sino AG | 229.08M |